AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.

Turmeric's active compound, curcumin, is a potent anti-inflammatory and antioxidant that can help with conditions like ...

Your COPD is considered to be moderate. Your FEV1 is between 30% and 49% of the normal predicted values, and your FEV1/FVC is less than 70%. In this stage, you may experience shortness of breath ...

Although no cause of death or further details were given, the news comes months after Lynch announced he had been living with ...

Verona Pharma stock hit a record high Thursday on continued enthusiasm for its newly launched COPD treatment, Ohtuvayre.

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

The health department on January 10 issued orders to all medical officers and civic hospitals to start surveillance and ...

Legendary filmmaker David Lynch passed away months after he was diagnosed with emphysema, a lung disease that results from ...

Arogya Aarohan app & other AI-driven tools are being tested for early detection of diseases as part of Rs 300-cr initiative ...

The Air Quality Index (AQI) can tell you a lot about the health of the environment, but there are still measures you can take ...